In the latest issue of Breast Cancer Update (2006 issue 4) in an audio interview Dr Cathy Miller (who has been involved in various clinical trials) describes the potential benefits of small molecule tyrosine kikase inhibitors (SMTKIs) in breast cancer. This still early in clinical research but may be of interest to you.
You can access the website at:
http://www.breastcancerupdate.com/do.../4/default.asp
The audio tracks of interest (if you do not want to listen to the complete interview are # 10 & 11
http://www.breastcancerupdate.com/do...4_06_Jones.mp3
Track 10
Potential role of small molecule tyrosine kinase inhibitors (SMTKIs) in breast cancer
Track 11
Case discussion: Woman with ER/PR/HER2-negative metastatic disease treated with a SMTKI